British drugmaker GSK https://www.reuters.com/markets/companies/GSK.L” target=”_blank” rel=”noopener”>(GSK.L) said on Monday its cancer drug Jemperli when combined with chemotherapy, met the primary goal of overall survival in patients with advanced or recurren…
Read More
About The Author
